Orion Pharma Statistics

Total Valuation

Orion Pharma has a market cap or net worth of BDT 6.15 billion. The enterprise value is 31.23 billion.

Market Cap	6.15B
Enterprise Value	31.23B

Important Dates

The last earnings date was Sunday, April 27, 2025.

Earnings Date	Apr 27, 2025
Ex-Dividend Date	Dec 5, 2024

Share Statistics

Orion Pharma has 234.00 million shares outstanding.

Current Share Class	234.00M
Shares Outstanding	234.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.99
PB Ratio	0.28
P/TBV Ratio	0.29
P/FCF Ratio	125.00
P/OCF Ratio	2.94
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.77, with an EV/FCF ratio of 634.27.

EV / Earnings	-285.48
EV / Sales	5.04
EV / EBITDA	25.77
EV / EBIT	54.71
EV / FCF	634.27

Financial Position

The company has a current ratio of 1.99, with a Debt / Equity ratio of 1.06.

Current Ratio	1.99
Quick Ratio	1.69
Debt / Equity	1.06
Debt / EBITDA	19.73
Debt / FCF	482.00
Interest Coverage	1.06

Financial Efficiency

Return on equity (ROE) is -0.63% and return on invested capital (ROIC) is 0.77%.

Return on Equity (ROE)	-0.63%
Return on Assets (ROA)	0.66%
Return on Invested Capital (ROIC)	0.77%
Return on Capital Employed (ROCE)	1.22%
Revenue Per Employee	1.96M
Profits Per Employee	-34,617
Employee Count	3,160
Asset Turnover	0.12
Inventory Turnover	2.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.18% in the last 52 weeks. The beta is -0.59, so Orion Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.59
52-Week Price Change	-64.18%
50-Day Moving Average	30.13
200-Day Moving Average	39.93
Relative Strength Index (RSI)	33.69
Average Volume (20 Days)	242,028

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orion Pharma had revenue of BDT 6.19 billion and -109.39 million in losses. Loss per share was -0.47.

Revenue	6.19B
Gross Profit	1.79B
Operating Income	561.83M
Pretax Income	29.06M
Net Income	-109.39M
EBITDA	1.19B
EBIT	561.83M
Loss Per Share	-0.47

Full Income Statement

Balance Sheet

The company has 135.24 million in cash and 23.73 billion in debt, giving a net cash position of -23.58 billion or -100.78 per share.

Cash & Cash Equivalents	135.24M
Total Debt	23.73B
Net Cash	-23.58B
Net Cash Per Share	-100.78
Equity (Book Value)	22.36B
Book Value Per Share	89.18
Working Capital	8.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.10 billion and capital expenditures -2.05 billion, giving a free cash flow of 49.24 million.

Operating Cash Flow	2.10B
Capital Expenditures	-2.05B
Free Cash Flow	49.24M
FCF Per Share	0.21

Full Cash Flow Statement

Margins

Gross margin is 28.94%, with operating and profit margins of 9.07% and -1.77%.

Gross Margin	28.94%
Operating Margin	9.07%
Pretax Margin	0.47%
Profit Margin	-1.77%
EBITDA Margin	19.14%
EBIT Margin	9.07%
FCF Margin	0.80%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.72%.

Dividend Per Share	1.00
Dividend Yield	3.72%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.72%
Earnings Yield	-1.78%
FCF Yield	0.80%

Dividend Details

Stock Splits

The last stock split was on May 27, 2013. It was a forward split with a ratio of 1.2.

Last Split Date	May 27, 2013
Split Type	Forward
Split Ratio	1.2

Scores

Orion Pharma has an Altman Z-Score of 0.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.73
Piotroski F-Score	n/a